Abnormal cortical development sets the stage in Huntington disease
Journal of Huntington's Disease · 2026
DOI: 10.1177/18796397261426033 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Huntington's Disease, 2026. Verfasst von Marine Degennaro und 2 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, Paris, France. Hauptthemen laut MEDLINE: Huntington Disease, Huntingtin Protein, Cerebral Cortex. Die Arbeit nennt 82 Literaturangaben. Gefördert von: Agence Nationale de la Recherche, Hereditary Disease Foundation, Fondation pour la Recherche Médicale.
Abstract (Originalsprache)
One of the great mysteries of Huntington disease (HD) is its adult onset. HD is caused by a CAG repeat expansion in the HTT gene, which encodes a protein (HTT) that is crucial for intracellular transport and neuronal growth, so one would expect development to be altered in some way. Human fetal samples, cell and animal model studies have shown that neurodevelopment is indeed altered in HD. Structural and functional abnormalities can be detected during the presymptomatic phase, and mutation carriers may display subtle cognitive deficits, psychiatric disturbances, or motor impairments years before clinical diagnosis. However, despite these early developmental alterations and the lifelong presence of mutant huntingtin (mHTT), HD carriers typically experience a long asymptomatic period. In this review, we provide an overview of the functions of HTT and the dysfunctions caused by mHTT or HTT loss during development, from gastrulation to neurulation, and examine the specific contribution of the cerebral cortex in HD. Drawing on nearly 25 years of research, we integrate studies ranging from in vitro to in vivo studies, highlighting the molecular mechanisms that contribute to HD neuropathology. Understanding these early developmental processes may define a window for therapeutic intervention, a period of plasticity during which the brain may still correct or compensate for developmental errors. This could strengthen the foundations to extend the presymptomatic phase and delay neurodegeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, Paris, France.
ORCID-Profile: Marine Degennaro, Sandrine Humbert, Mariacristina Capizzi
Förderung
- Agence Nationale de la Recherche
- Hereditary Disease Foundation
- Fondation pour la Recherche Médicale
Zitieren
APA
Degennaro, M., Humbert, S., & Capizzi, M. (2026). Abnormal cortical development sets the stage in Huntington disease. Journal of Huntington's Disease. https://doi.org/10.1177/18796397261426033
Vancouver
Degennaro M, Humbert S, Capizzi M. Abnormal cortical development sets the stage in Huntington disease. Journal of Huntington's Disease. 2026. doi:10.1177/18796397261426033
BibTeX
@article{Degennaro2026,
author = {Degennaro, Marine and Humbert, Sandrine and Capizzi, Mariacristina},
title = {Abnormal cortical development sets the stage in Huntington disease},
journal = {Journal of Huntington's Disease},
year = {2026},
doi = {10.1177/18796397261426033}
}
EUVIMED